Cladribine is an antimetabolite that causes cell arrest in G1 in B-cell lymphoma cells by modulating the activity of apoptotic proteins, notably c-FlipL, Bax, and Death receptor 4 (DR4) and Caspase 8. Here, CASP8 is linked to B-cell non-Hodgkin lymphoma.